0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query gir global glioblastoma multiforme therapeutics market 2018 manufacturers regions type.Your search for "" gave back 1533064 results.
Recurrent glioblastoma multiforme is the most aggressive cancer that begins within the brain. Market Analysis and Insights: Global Recurrent...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Recurrent glioblastoma multiforme is the most aggressive cancer that begins within the brain. The “Recurrent Glioblastoma Multiforme (GBM) Treatment...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) - Pipeline Review, H2 2018 Summary...
Catalog:
Global Markets Direct
September 2018
Price: USD 3,500.00
Exportin 1 - Pipeline Review, H2 2020 Summary Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) pipeline Target constitutes close...
Catalog:
Global Markets Direct
August 2020
Price: USD 3,500.00
Exportin 1 - Pipeline Review, H2 2019 Summary According to the recently published report 'Exportin 1 - Pipeline Review, H2 2019'; Exportin...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Recurrent glioblastoma multiforme is the most aggressive cancer that begins within the brain. Highlights The global Recurrent Glioblastoma Multiforme...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The global Recurrent Glioblastoma Multiforme (GBM) Treatment market size was valued at US$ 453.4 million in 2023. With growing demand in downstream...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Indoleamine 2,3 Dioxygenase 1 (Indoleamine Pyrrole 2,3 Dioxygenase 1 or IDO1 or EC 1.13.11.52) - Drugs in Development, 2021 Summary According to the...
Catalog:
Global Markets Direct
March 2021
Price: USD 3,500.00
Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A (Serine/Threonine Kinase MNB or MNB/DYRK Protein Kinase or Dual specificity YAK1...
Catalog:
Global Markets Direct
February 2018
Price: USD 3,500.00
Recurrent glioblastoma multiforme is the most aggressive cancer that begins within the brain. The global Recurrent Glioblastoma Multiforme (GBM)...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Carbonic Anhydrase 9 - Pipeline Review, H2 2019 Summary According to the recently published report 'Carbonic Anhydrase 9 - Pipeline Review, H2...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Tyrosine Protein Kinase CSK - Pipeline Review, H1 2020 Summary According to the recently published report 'Tyrosine Protein Kinase CSK –...
Catalog:
Global Markets Direct
June 2020
Price: USD 3,500.00
Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) Development by Therapy Areas and Indications, Stages,...
Catalog:
Global Markets Direct
March 2022
Price: USD 3,500.00
The global Glioblastoma Multiforme Treatment (GBM) market size was valued at US$ 536.3 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Drugs in Development, 2021 Summary Fibroblast Growth Factor Receptor 4 (CD334...
Catalog:
Global Markets Direct
March 2021
Price: USD 3,500.00
